454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation, in collaboration with scientists at Dana Farber Cancer Center and Broad Institute, today reported a new method for the detection of cancer gene mutations present at extremely low levels.
It is heartwarming to see that the scientific community is working ever closer to curing cancer. I just wish they could have saved my aunt from dying of breast cancer. :/
0 Responses to “Dana Farber and 454 life sciences announce breakthrough in DNA sequencing”
Leave a Reply